NCT00678457View on ClinicalTrials.gov

Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Alcohol Dependence
Interventions
DRUG

Ondansetron

ondansetron (4 μg/kg b.i.d.)

DRUG

Olanzapine

olanzapine (9, 18, and 36 μg/kg)

DRUG

Placebo

placebo

Trial Locations (2)

22911

UVA CARE, Charlottesville

23294

UVA CARE Richmond, Richmond

All Listed Sponsors
lead

University of Virginia

OTHER

NCT00678457 - Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial | Biotech Hunter | Biotech Hunter